These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 28812924)

  • 1. Susceptibility testing and reporting of new antibiotics with a focus on tedizolid: an international working group report.
    Wilcox MH; Dmitrieva N; Gales AC; Petukhova I; Al-Obeid S; Rossi F; M Blondeau J
    Future Microbiol; 2017 Dec; 12():1523-1532. PubMed ID: 28812924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harmonization of antimicrobial susceptibility testing breakpoints in Europe: implications for reporting intermediate susceptibility.
    Brown D; Macgowan A
    J Antimicrob Chemother; 2010 Feb; 65(2):183-5. PubMed ID: 19996143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surveillance of tedizolid activity and resistance: In vitro susceptibility of Gram-positive pathogens collected over 5 years from the United States and Europe.
    Bensaci M; Sahm D
    Diagn Microbiol Infect Dis; 2017 Feb; 87(2):133-138. PubMed ID: 27866673
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Brown-Elliott BA; Wallace RJ
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28923878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of the surveillance of Tedizolid activity and resistance program: in vitro susceptibility of gram-positive pathogens collected in 2011 and 2012 from the United States and Europe.
    Sahm DF; Deane J; Bien PA; Locke JB; Zuill DE; Shaw KJ; Bartizal KF
    Diagn Microbiol Infect Dis; 2015 Feb; 81(2):112-8. PubMed ID: 25488274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In Vitro activities of Tedizolid and comparator antimicrobial agents against clinical isolates of Staphylococcus aureus collected in 12 countries from 2014 to 2016.
    Karlowsky JA; Hackel MA; Bouchillon SK; Alder J; Sahm DF
    Diagn Microbiol Infect Dis; 2017 Oct; 89(2):151-157. PubMed ID: 28793964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Widespread implementation of EUCAST breakpoints for antibacterial susceptibility testing in Europe.
    Brown D; Canton R; Dubreuil L; Gatermann S; Giske C; MacGowan A; Martinez-Martinez L; Mouton J; Skov R; Steinbakk M; Walton C; Heuer O; Struelens MJ; Diaz Hogberg L; Kahlmeter G
    Euro Surveill; 2015 Jan; 20(2):. PubMed ID: 25613780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimicrobial susceptibility testing and patterns of resistance at a tertiary care center.
    Akhter J; Qutub MO; Qadri SM
    Saudi Med J; 2001 Jul; 22(7):569-76. PubMed ID: 11479635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Activities of Tedizolid and Linezolid against Gram-Positive Cocci Associated with Acute Bacterial Skin and Skin Structure Infections and Pneumonia.
    Chen KH; Huang YT; Liao CH; Sheng WH; Hsueh PR
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6262-5. PubMed ID: 26248355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activities of Tedizolid and Linezolid Determined by the Reference Broth Microdilution Method against 3,032 Gram-Positive Bacterial Isolates Collected in Asia-Pacific, Eastern Europe, and Latin American Countries in 2014.
    Pfaller MA; Flamm RK; Jones RN; Farrell DJ; Mendes RE
    Antimicrob Agents Chemother; 2016 Sep; 60(9):5393-9. PubMed ID: 27353270
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Brown-Elliott BA; Wallace RJ
    J Clin Microbiol; 2017 Jun; 55(6):1747-1754. PubMed ID: 28330892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of Tedizolid phosphate against multidrug-resistant Streptococcus pneumoniae isolates from Asian countries.
    Baek JY; Kang CI; Kim SH; Ko KS; Chung DR; Peck KR; Hsueh PR; Thamlikitkul V; So TM; Lee NY; Song JH;
    Diagn Microbiol Infect Dis; 2016 Jun; 85(2):218-20. PubMed ID: 27083121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of tedizolid against methicillin-resistant Staphylococcus aureus and Peptostreptococcus anaerobius in thigh mixed-infection mouse model.
    Yamagishi Y; Mikamo H; Kato H; Nishiyama N; Asai N; Koizumi Y; Sakanashi D; Suematsu H; Matsuura K; Hagihara M
    J Infect Chemother; 2017 Jun; 23(6):368-373. PubMed ID: 28343752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of tedizolid and linezolid against Staphylococcus epidermidis isolated from prosthetic joint infections.
    Littorin C; Hellmark B; Nilsdotter-Augustinsson Å; Söderquist B
    Eur J Clin Microbiol Infect Dis; 2017 Sep; 36(9):1549-1552. PubMed ID: 28326447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of tedizolid against staphylococci isolated from prosthetic joint infections.
    Schmidt-Malan SM; Greenwood Quaintance KE; Karau MJ; Patel R
    Diagn Microbiol Infect Dis; 2016 May; 85(1):77-9. PubMed ID: 26906190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of tedizolid against Staphylococcus aureus and Streptococcus pneumoniae collected in 2013 and 2014 from sites in Latin American countries, Australia, New Zealand, and China.
    Biedenbach DJ; Bouchillon SK; Johnson B; Alder J; Sahm DF
    Eur J Clin Microbiol Infect Dis; 2016 Dec; 35(12):1933-1939. PubMed ID: 27677280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards a rational antimicrobial testing policy in the laboratory.
    Banaji N; Oommen S
    Indian J Med Microbiol; 2011; 29(3):209-12. PubMed ID: 21860098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
    Barber KE; Smith JR; Raut A; Rybak MJ
    J Antimicrob Chemother; 2016 Jan; 71(1):152-5. PubMed ID: 26476277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a national EUCAST challenge panel for antimicrobial susceptibility testing.
    Desmet S; Verhaegen J; Glupzcynski Y; Van Eldere J; Melin P; Goossens H; Piérard D; Declercq P; Lagrou K; Boel A; Cartuyvels R; Denis O; Vandewal W; Saegeman V
    Clin Microbiol Infect; 2016 Aug; 22(8):704-10. PubMed ID: 27234934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Towards better antimicrobial susceptibility testing: impact of the Journal of Antimicrobial Chemotherapy.
    Wootton M; MacGowan AP; Howe RA
    J Antimicrob Chemother; 2017 Feb; 72(2):323-329. PubMed ID: 28115501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.